PREVIOUS PAPERS

Denamur E. et al.
The population genetics of pathogenic Escherichia coli.
Nat. Rev. Microbiol. 2020 Aug 21

Grzelak L. et al.
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
Sci. Transl. Med. 2020 Aug 17

Rodrigues C. et al.
Community-acquired infection caused by the uncommon hypervirulent Klebsiella pneumoniae ST66-K2 lineage.
Microb. Genom. 2020 Aug 4

Hobson C.A. et al.
Urine zinc concentrations allow proper expression of metallo-β-lactamases in Enterobacteriaceae.
J. Antimicrob. Chemother. 2020 Jul 25

Atlani-Duault L. et al.
France’s COVID-19 response: balancing conflicting public health traditions.
Lancet 2020 Jul 25

Poline J. et al.
Systematic SARS-CoV-2 screening at hospital admission in children: a French prospective multicenter study.
Clin. Infect. Dis. 2020 Jul 25

Maisonnasse P. et al.
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
Nature 2020 Jul 22

Lê M.P. et al.
Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients.
J. Antimicrob. Chemother. 2020 Jul 20

Canovas J. et al.
Expression of CTX-M-15 limits the efficacy of ceftolozane/tazobactam against Escherichia coli in a high-inoculum murine peritonitis model.
Clin. Microbiol. Infect. 2020 Jul 2

Ouldali N. et al.
Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
Lancet Child Adolesc. Health 2020 Jul 2

Peiffer-Smadja N. et al.
Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia.
Crit. Care 2020 Jun 19

Gonçalves A. et al.
Timing of antiviral treatment initiation is critical to reduce SARS-CoV-2 viral load.
CPT Pharmacometrics Syst. Pharmacol. 2020 Jun 18

Kemble H. et al.
Flux, toxicity, and expression costs generate complex genetic interactions in a metabolic pathway.
Science Advances 2020 Jun 3

Lê M.P. et al.
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
J. Antimicrob. Chemother. 2020 May 30

Roujansky A. et al.
Analysis of paradoxical efficacy of carbapenems against carbapenemase-producing Escherichia coli in a murine model of lethal peritonitis.
Antimicrob. Agents Chemother. 2020 May 18

de Lastours V. et al.
Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
J. Antimicrob. Chemother. 2020 May 17

Jacquier H. et al.
Molecular epidemiology of Neisseria gonorrhoeae clinical isolates in Reunion and Mayotte.
Sex. Transm. Infect. 2020 May 4

Deslandes A. et al.
SARS-CoV-2 was already spreading in France in late december 2019.
Int. J. Antimicrob. Agents 2020 May 3

Delory T. et al.
A Computerized Decision Support System (CDSS) for antibiotic prescription in primary care-antibioclic: implementation, adoption and sustainable Use in the era of extended antimicrobial resistance.
J. Antimicrob. Chemother. 2020 May 1

Visseaux B. et al.
Evaluation of the QIAstat-Dx respiratory SARS-CoV-2 panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection.
J. Clin. Microbiol. 2020 Apr 27

Andremont O. et al.
Semi-quantitative cultures of throat and rectal swabs are efficient tests to predict ESBL-Enterobacterales ventilator-associated pneumonia in mechanically ventilated ESBL carriers.
Intensive Care Med. 2020 Apr 20

Jouvin-Marche E. et al.
French research strategy to tackle antimicrobial resistance.
Lancet 2020 Apr 18

Caméléna F. et al.
Genomic characterization of 16S rRNA methyltransferase-producing Escherichia coli isolates from the Parisian area, France.
J. Antimicrob. Chemother. 2020 Apr 16

Sallard E. et al.
Type 1 interferons as a potential treatment against COVID-19.
Antiviral Res. 2020 Apr 7

Lescure FX. et al.
Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
Lancet Infect. Dis. 2020 Mar 27

Madelain V. et al.
Modeling favipiravir antiviral efficacy against emerging viruses: from animal studies to clinical trials.
CPT Pharmacometrics Syst. Pharmacol. 2020 Mar 20

Choudhury A. et al.
CRISPR/Cas9 recombineering-mediated deep mutational scanning of essential genes in Escherichia coli.
Mol. Syst. Biol. 2020 Mar 16

Marcelin AG. et al.
Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients.
J. Antimicrob. Chemother 2020 Mar 10

Cointe A. et al.
Escherichia coli O80 hybrid pathotype strains producing Shiga toxin and ESBL: molecular characterization and potential therapeutic options.
J. Antimicrob. Chemother. 2020 Mar 1

Charpentier C. et al.
Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial).
J. Antimicrob. Chemother. 2020 Feb 24

Riglet F. et al.
Bayesian individual dynamic predictions with uncertainty of longitudinal biomarkers and risks of survival events in a joint modelling framework: a comparison between Stan, Monolix, and NONMEM.
AAPS J. 2020 Feb 19

Peiffer-Smadja N. et al.
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?
Clin. Microbiol. Infect. 2020 Feb 12

Hobson CA et al.
Impact of anticancer chemotherapy on the extension of beta-lactamase spectrum: an example with KPC-type carbapenemase activity towards ceftazidime-avibactam.
Sci. Rep. 2020 Jan 17

Tubiana S. et al.
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long term disability and determinants of outcome in a multicentre prospective cohort.
Clin. Microbiol. Infect. 2020 Jan 9

Le Hingrat Q. et al.
Genetic variability of long terminal repeat region between HIV-2 groups impacts transcriptional activity.
J. Virol. 2020 Jan 8

Click here to see our previous papers in 2019

Maataoui N. et al.
Increased risk of acquisition and transmission of ESBL-producing Enterobacteriaceae in malnourished children exposed to amoxicillin.
J. Antimicrob. Chemother. 2019 Dec 10

Jacquier H. et al.
Benefits of polymerase chain reaction combined with culture for the diagnosis of bone and joint infections: a prospective test performance study.
Open Forum Infect. Dis. 2019 Dec 2

Mentré F. et al.
Pharmacometrics and systems pharmacology 2030.
Clin Pharmacol Ther. 2019 Nov 23

Vaillant L. et al.
Awareness among French healthcare workers of the transmission of multidrug resistant organisms: a large cross-sectional survey.
Antimicrob Resist Infect Control. 2019 Nov 12

Ibn Saied W. et al.
Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: risk factors and outcome.
J Infect. 2019 Nov 2

Visseaux B. et al.
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?
J. Antimicrob. Chemother. 2019 Oct 22

Saint-Lu N. et al.
DAV131A protects hamsters from lethal Clostridioides difficile infection induced by fluoroquinolones.
Antimicrob Agents Chemother. 2019 Oct 21

Buetti N. et al.
Short-term dialysis catheter versus central venous catheter infections in ICU patients: a post hoc analysis of individual data of 4 multi-centric randomized trials.
Intensive Care Med. 2019 Oct 17

Birgy A. et al.
Diversity and trends in population structure of ESBL-producing Enterobacteriaceae in febrile urinary tract infections in children in France from 2014 to 2017.
J. Antimicrob. Chemother. 2019 Oct 16

Eholie S. et al.
Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study. Lancet HIV 2019 Oct 7

Tubiana S. et al.
Attitudes, knowledge, and willingness to be vaccinated against seasonal influenza among patients hospitalized with Influenza-Like-Illness: impact of diagnostic testing.
Hum. Vaccin. Immunother. 2019 Oct 7

Mahérault A-C. et al.
Advantage of the F2:A1:B- IncF pandemic plasmid over IncC plasmids in in vitro acquisition and evolution of bla_CTX-M gene-bearing plasmids in Escherichia coli.
Antimicrob. Agents Chemother. 2019 Sep 23

Morvan AC. et al.
Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical care-an analysis of the OUTCOMEREA database.
Crit. Care. 2019 Sep 6

Ghalayini M. et al.
Long-term evolution of the natural isolate of Escherichia coli 536 in the mouse gut colonized after maternal transmission reveals convergence in the constitutive expression of the lactose operon.
Mol Ecol 2019 Sep 4

Mandelbrot L. et al.
Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model.
PLoS One 2019 Aug 13

Branger C. et al.
Specialization of small non-conjugative plasmids in Escherichia coli according to their family types.
Microb. Genom. 2019 Aug 7

Dufour N. et al.
Phage Therapy of pneumonia is not associated with an overstimulation of the inflammatory response compared to antibiotic areatment in mice.
Antimicrob. Agents Chemother. 2019 Jul 25

Burdet C. et al.
Impact of antibiotic gut exposure on the temporal changes in microbiome diversity.
Antimicrob. Agents Chemother. 2019 Jul 15

Couce A. and Tenaillon O.
Mutation bias and GC content shape antimutator invasions.
Nat. Commun. 2019 Jul 15

Loubet P. et al.
Community-acquired pneumonia in the emergency department: an algorithm to facilitate diagnosis and guide chest CT scan indication.
Clin. Microbiol. Infect. 2019 Jul 5

Castain L. et al.
New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations.
J. Antimicrob. Chemother. 2019 Jul 1

Birgy A. et al.
Independent host factors and bacterial genetic determinants of the emergence and dominance of Escherichia coli sequence type 131 CTX-M-27 in a community pediatric cohort study.
Antimicrob. Agents Chemother. 2019 Jun 24

Kieffer N. et al.
mcr-9, an inducible gene encoding an acquired phosphoethanolamine transferase in Escherichia coli, and its origin.
Antimicrob. Agents Chemother. 2019 Jun 17

Perozziello A. et al.
Prescribers’ experience and opinions on antimicrobial stewardship programmes in hospitals: a French nationwide survey.
J. Antimicrob. Chemother. 2019 Jun 5

Seurat J. et al.
Robust designs accounting for model uncertainty in longitudinal studies with binary outcomes.
Stat. Methods Med. Res. 2019 Jun 5.

Burdet C. et al.
Ceftriaxone and cefotaxime have similar effects on the intestinal microbiota in human volunteers treated by standard-dose regimens.
Antimicrob. Agents Chemother. 2019 May 24.

	Bailly S. et al. Impact of loading dose of caspofungin in PK/PD target attainment for severe candidiasis infections in ICU patients - the CASPOLOAD study. Antimicrob. Agents Chemother. 2020 Aug 21

	Massot M. et al. Temporal dynamics of the fecal microbiota in veal calves in a 6-month field trial. Animal Microbiome 2020 Sep 15

	Petit M. et al. Rapid detection and characterization of carbapenemases in Enterobacterales with a new modified carbapenem inactivation method: mCIMplus. J. Clin. Microbiol. 2020 Sep 2

	Fontaine C. et al. Relationship between the composition of the intestinal microbiota and the tracheal and intestinal colonization by opportunistic pathogens in intensive care patients. PLoS One. 2020 Aug 28